Stockscreener 앱 받기
2.25%
시간 외 거래:
전일 마감가:
$155.14
열려 있는:
$154.87
하루 거래량:
579.44K
Relative Volume:
0.59
시가총액:
$10.00B
수익:
$13.64B
순이익/손실:
$1.05B
주가수익비율:
15.87
EPS:
9.555
순현금흐름:
$1.31B
1주 성능:
-0.13%
1개월 성능:
+0.87%
6개월 성능:
+27.42%
1년 성능:
+7.98%
1일 변동 폭
$151.27
$155.84
1주일 범위
$149.35
$155.84
52주 변동 폭
$101.00
$159.42
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
151.65 | 10.23B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
433.09 | 96.38B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
183.27 | 15.52B | 21.46B | 2.65B | 3.32B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.49 | 12.33B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
183.72 | 10.91B | 5.06B | 344.26M | 370.71M | 5.8446 |
EHC
Encompass Health Corp
|
107.48 | 9.94B | 5.94B | 758.60M | 439.20M | 5.5418 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
Can Execution and Volume Trends Support DaVita's Q1 Earnings? - Yahoo Finance
Here is What to Know Beyond Why DaVita Inc. (DVA) is a Trending Stock - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Sells 12,843 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. Stock (US23918K1088): Q1 2026 Earnings Release on Track for April 30 - AD HOC NEWS
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
How Analyst Model Shifts Are Rewriting The DaVita (DVA) Investment Narrative - Yahoo Finance
Early Integrated Kidney Care Profitability Could Be A Game Changer For DaVita (DVA) - Sahm
Evaluating Innovations in Middle Molecule Clearance - DaVita Newsroom
M&T Bank Corp Acquires 19,500 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why did DaVita stock jump 15% after hours today? - MSN
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with Strong Revenue Growth and High ROE - DirectorsTalk Interviews
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
Teachers Retirement System of The State of Kentucky Has $21.29 Million Stock Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc (BSP:DVAI34) Stock Price & 30 Year Financial Data - GuruFocus
DaVita Inc. $DVA Stock Position Decreased by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Asset Management One Co. Ltd. Cuts Stock Holdings in DaVita Inc. $DVA - MarketBeat
DaVita’s Profitable Kidney Care Platform Recasts Value Based Growth Story - Sahm
DaVita Q4 2025 earnings preview - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is It Time To Reassess DaVita (DVA) After Its Strong Year To Date Rally? - simplywall.st
DaVita Inc Forecasts Strong EPS Growth Ahead of Q1 2026 Earnings - HarianBasis.co
What’s So Good About DaVita (DVA) That Warren Buffett Remains Bullish On It Since 15 Years? - Insider Monkey
Here's why you should retain DaVita stock in your portfolio for now - MSN
Dialysis Giant DaVita Defends Itself In Court And At The Polls - KFF Health News
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
DaVita (NYSE: DVA) details 2026 virtual meeting, board slate and say-on-pay - Stock Titan
What to Expect From DaVita's Next Quarterly Earnings Report - Yahoo Finance
DaVita Inc. stock (US23918K1088): Why does its dialysis dominance still drive U.S. investor value? - AD HOC NEWS
Outpatient & Specialty Care Stocks Q4 Earnings Review: DaVita (NYSE:DVA) Shines - Yahoo Finance
DaVita Inc. (NYSE:DVA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $203,000 Position in DaVita Inc. $DVA - MarketBeat
Lobbying Update: $1,200,000 of DAVITA INC lobbying was just disclosed - Quiver Quantitative
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call - The Malaysian Reserve
DaVita (DVA) Stock: Support and Resistance Zones (Touches High) 2026-04-20Retail Picks - Cổng thông tin điện tử tỉnh Tây Ninh
DaVita Inc stock (US23804L1035): Is its dialysis network dominance the real long-term edge? - AD HOC NEWS
Kidney Dialysis Equipment Market Is Booming So Rapidly| Davita - openPR.com
DaVita Inc. (DVA) Stock Analysis: Navigating Growth With A 64.85% Return On Equity - DirectorsTalk Interviews
DaVita Inc stock (US23804L1035): Why Google Discover changes matter more now - AD HOC NEWS
DaVita Clinical Research Celebrates Milestone Year - Yahoo
Lecap Asset Management Ltd. Invests $992,000 in DaVita Inc. $DVA - MarketBeat
KBC Group NV Raises Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc (DVA) Shares Fall 3.3% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): Is kidney care demand strong enough to drive steady investor retur - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock rises Monday, still underperforms market - MarketWatch
DaVita Inc stock (US23804L1035): Why its kidney care dominance matters more now for investors - AD HOC NEWS
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다비타 주식 (DVA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ACKERMAN JOEL | CFO and Treasuer |
Feb 06 '26 |
Option Exercise |
108.93 |
44,065 |
4,800,000 |
185,705 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jan 29 '26 |
Sale |
120.56 |
1,658,480 |
199,939,881 |
30,100,585 |
| HEARTY JAMES O | Chief Compliance Officer |
Dec 04 '25 |
Option Exercise |
108.93 |
5,875 |
639,964 |
31,913 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Oct 27 '25 |
Sale |
135.36 |
401,514 |
54,347,249 |
31,759,065 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jul 31 '25 |
Sale |
140.61 |
1,635,962 |
230,024,764 |
32,160,579 |
| HEARTY JAMES O | Chief Compliance Officer |
Jul 23 '25 |
Sale |
150.00 |
2,351 |
352,650 |
26,038 |
0.75%
7.48%
자본화:
|
볼륨(24시간):